CD8A and neoplasm: Simple hepatobiliary tumor organoids without immune components have been applied to detect neoantigen peptides and elicit peptide-specific CD8+ T cells that can precisely target tumor cells (74), while co-culture systems with HCC organoids and autologous PBMC showed huge promise for CAR-T development.